All Viruses articles – Page 32
-
NewsSewage could act as early warning system for influenza A outbreaks
Researchers monitoring wastewater for avian and human influenza A virus have detected a surge in virus as the flu season got underway, showing that the technique could act as an early warning system for these and other pathogens. Genetic material closely related to that found in the H5N1 strain of ...
-
NewsCommon cold virus exposure may help usher in immunity to Covid
Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study.
-
NewsGut microbiome can increase risk and severity of HIV and EBV disease
Researchers have shown that the microbiome has a significant impact on the acquisition of Epstein-Barr virus (EBV) and human immunodeficiency virus-1 (HIV) infection and plays a role in the course of disease.
-
NewsScientists discover broadly neutralizing antibodies that contribute to HIV control
Researchers have investigated and revealed how neutralizing antibodies, including those described as broadly neutralizing, contribute to HIV control.
-
NewsResearchers reveal how the herpes virus HCMV deceives its host cells
Researchers have created a detailed map of the spatial interactions between viral and host cell proteins within HCMV particles, revealing that certain host cell proteins are recruited by viral proteins and play a role in viral replication.
-
NewsFlu deaths rise when pro sports teams move into cities
West Virginia University economists, whose research shows flu deaths increase when a city becomes home to a new professional sports team, say their data should make even the biggest fans reconsider support for taxpayer-funded stadium subsidies.
-
NewsGene-editing technology eliminates EV-A71 RNA viruses
Scientists have developed a CRISPR-Cas13 therapeutic against EV-A71, the RNA virus that causes hand, foot, and mouth disease.
-
NewsNew Drosophila toolkit to help reveal how Covid-19 virus impacts human health
Researchers have developed a toolkit of <i>Drosophila melanogaster</i> COVID-19 resources to study how viral and human proteins interact, with the goal of developing therapies for symptoms caused by existing and new strains.
-
OpinionNew RSV vaccines on the way - so what do we do about vaccine hesitancy?
Not one, but two promising new vaccines are likely to be introduced to the UK, yet routine childhood vaccination rates have been decreasing for ‘old’ diseases like measles and polio - what’s going on?
-
NewsNew HIV drug formulation could improve treatment outcomes for children worldwide
Researchers have confirmed the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).
-
NewsModerna is safest, most effective mRNA vaccine against COVID-19 for older adults
A study of older US adults found that the risk of negative effects of both mRNA vaccines is exceptionally low, but lowest with the Moderna vaccine.
-
NewsNovel molecules fight viruses by bursting their bubble-like membranes
Researchers show how a group of novel molecules inspired by our own immune system inactivates several viruses, including Zika and chikungunya, by targeting the viral membranes, rather than the proteins.
-
NewsCOVID-19 vaccination reduces severity and mortality after breakthrough infections
Among individuals recently infected with SARS-CoV-2, those who were fully vaccinated had lower concentrations of almost all inflammation markers (cytokines and chemokines) than those who were unvaccinated in the short-term and long-term after symptomatic SARS-CoV-2 infection.
-
NewsKey gene for resistance to HIV replication found in people of African ancestry
Scientists have identified a novel region in the genome that is only variable in populations of African ancestries and provided evidence that the gene CHD1L acts to limit HIV replication in a subset of white blood cells.
-
NewsResearchers create total synthesis of HIV replication inhibitor
Scientists appear to have discovered a way to produce a true structure of the rare but naturally-occurring anti-HIV compound Lancilactone C from start to finish.
-
News‘Time-travelling’ pathogens in melting permafrost pose likely risk to environment
Ancient pathogens that escape from melting permafrost have real potential to damage microbial communities and might potentially threaten human health, a new study suggests.
-
NewsSwine flu strain has passed from humans to swine nearly 400 times since 2009
A new study of the strain of influenza A responsible for the 2009 H1N1 pandemic shows that the virus has passed from humans to swine about 370 times since 2009, and subsequent circulation in swine has resulted in the evolution of pdm09 variants that then jumped from swine to humans.
-
NewsThe Phage-Microbiome Consortium is launched
The International Society of Microbiota (ISM) has announced the launch of a new initiative: The Phage-Microbiome Consortium.
-
NewsEavesdropping viruses wait for bacterial signals before switching to kill mode
Researchers have found that dozens of viruses respond to quorum sensing or other chemical signals from bacteria.
-
NewsSpike protein mutants with low binding affinity usher in new Covid vaccine
Researchers have succeeded in producing a new vaccine against the SARS-CoV-2 coronavirus by identifying spike protein mutants that lack binding affinity.
